Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). MustGrow Biologics's share price for the quarter that ended in Jun. 2026 was C$0.385. MustGrow Biologics's Shares Outstanding (EOP) for the quarter that ended in Jun. 2026 was 70.44 Mil. Therefore, MustGrow Biologics's market cap for the quarter that ended in Jun. 2026 was C$27.12 Mil.
MustGrow Biologics's quarterly market cap
declined
from Dec. 2025 (C$37.08 Mil) to Mar. 2026 (C$33.37 Mil) and
declined
from Mar. 2026 (C$33.37 Mil) to Jun. 2026 (C$27.12 Mil).
MustGrow Biologics's annual market cap
declined
from Dec. 2023 (C$66.39 Mil) to Dec. 2024 (C$59.39 Mil) and
declined
from Dec. 2024 (C$59.39 Mil) to Dec. 2025 (C$37.08 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. MustGrow Biologics's Enterprise Value for Today is C$26.41 Mil.
MustGrow Biologics (TSXV:MGRO) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
MustGrow Biologics Market Cap Related Terms
MustGrow Biologics Market Cap Historical Data
* Premium members only.
The historical data trend for MustGrow Biologics's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Agricultural Inputs subindustry, MustGrow Biologics's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MustGrow Biologics Market Cap vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, MustGrow Biologics's Market Cap distribution charts can be found below:
* The bar in red indicates where MustGrow Biologics's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
MustGrow Biologics's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MustGrow Biologics (TSXV:MGRO) has a Market Cap of C$30.27 Mil as of Sep. 10, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on MustGrow Biologics and its competitors. According to the industry distribution chart, MustGrow Biologics ranks #208 out of 267 companies in the Agriculture industry, placing it in the top 77.9%.
Is MustGrow Biologics' Market Cap too high?
MustGrow Biologics' current Market Cap is C$30.27 Mil. Based on the distribution chart, MustGrow Biologics ranks #208 out of 267 companies in the Agriculture industry, which is in the bottom quartile relative to peers. Overall, MustGrow Biologics has a GF Score™ of 26/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does MustGrow Biologics' Market Cap compare to CTVA and CF?
According to the Agriculture industry distribution chart, MustGrow Biologics ranks #208 out of 267 companies for Market Cap. This places MustGrow Biologics in the lower half of its industry. The industry median Market Cap is 219.69. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for an Agriculture company?
The median Market Cap among Agriculture companies is 219.69, based on 267 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on MustGrow Biologics and its competitors. For the Agriculture industry, the median Market Cap is 219.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MustGrow Biologics's current Market Cap is C$30.27 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MustGrow Biologics stock overvalued right now?
Based on GuruFocus' analysis, MustGrow Biologics (TSXV:MGRO) is currently considered Possible Value Trap. The stock's GF Value™ is C$0.82, compared to a current price of C$0.43 — trading 47.6% below its estimated fair value. The current Market Cap is C$30.27 Mil. MustGrow Biologics' overall GF Score™ is 26/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For MustGrow Biologics (TSXV:MGRO), the current Market Cap is C$30.27 Mil as of Sep. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MustGrow Biologics (TSXV:MGRO) Overvalued in 2026?
Based on GuruFocus' analysis, MustGrow Biologics stock appears to be undervalued.
The current stock price of C$0.43 is trading 47.6% below its estimated GF Value™ of C$0.82.
GuruFocus considers MustGrow Biologics to be Possible Value Trap.
Key valuation signals for TSXV:MGRO:
Market Cap: C$30.27 Mil
GF Value™: C$0.82 vs. price of C$0.43 (47.6% below fair value)
No single metric tells the full story. See the TSXV:MGRO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MustGrow Biologics Corp is a fully integrated provider of biological and regenerative agriculture solutions designed to support sustainable farming. The Company's proprietary and third-party product lines offer eco-friendly alternatives to restricted or banned synthetic chemicals and fertilizers. It offers a portfolio of third-party crop nutrition solutions, including micronutrients, nitrogen stabilizers, biostimulants, and foliar products. These products are synergistically distributed alongside MustGrow's wholly owned proprietary products and technologies that are derived from mustard and developed into organic biocontrol and biofertility products to help replace banned or restricted synthetic chemicals and fertilizers.
26GF Score
Get the complete analysis for TSXV:MGRO
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSXV:MGRO has been successfully added to your 
